Roche argued that its obesity medications would prove to have advantages over its rivals’ — and that the demand for weight ...

The Temperature-Activated Generation of Signal (TAGS) technology was developed by Roche for its high-throughput PCR-based instruments.

The TAGS technology – or Temperature-Activated Generation of Signal to give it its full name – allows up to 15 diagnostic ...

Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for an injectable version of its blockbuster multiple sclerosis therapy Ocrevus, cutting down the time needed ...

FRANKFURT, Sept 11 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its shares in July ...

Work could lead to the discovery of new therapeutic targets. For the first time, researchers have identified "molecular ...

Roche introduces cobas Respiratory flex test to use its TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses: Basel Wednesday, September 25, 2024, ...

33 African countries have installed Roche molecular diagnostics systems, enabling reliable testing – a critical step to realising global elimination goals. We have seen our collective efforts ...

Roche Holding AG said it isn’t concerned about side effects in a small study of a weight-loss shot, after details about the trial sent shares tumbling on Monday. “We’re not alarmed at all ...

Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical company’s experimental obesity medicine. The poster, released as part ...

New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a ...